PL2766367T3 - Pochodne 4-amino-3-fenyloamino-6-fenylopirazolo[3,4-d]pirymidyny do leczenia infekcji wirusowych, zwłaszcza infekcji pikornawirusowych - Google Patents

Pochodne 4-amino-3-fenyloamino-6-fenylopirazolo[3,4-d]pirymidyny do leczenia infekcji wirusowych, zwłaszcza infekcji pikornawirusowych

Info

Publication number
PL2766367T3
PL2766367T3 PL12775659.1T PL12775659T PL2766367T3 PL 2766367 T3 PL2766367 T3 PL 2766367T3 PL 12775659 T PL12775659 T PL 12775659T PL 2766367 T3 PL2766367 T3 PL 2766367T3
Authority
PL
Poland
Prior art keywords
infections
phenylpyrazolo
phenylamino
amino
treatment
Prior art date
Application number
PL12775659.1T
Other languages
English (en)
Inventor
Peter Wutzler
Michaela Schmidtke
Vadim Makarov
Original Assignee
Scandion Oncology A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE201110116373 external-priority patent/DE102011116373A1/de
Application filed by Scandion Oncology A/S filed Critical Scandion Oncology A/S
Publication of PL2766367T3 publication Critical patent/PL2766367T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12775659.1T 2011-10-14 2012-10-15 Pochodne 4-amino-3-fenyloamino-6-fenylopirazolo[3,4-d]pirymidyny do leczenia infekcji wirusowych, zwłaszcza infekcji pikornawirusowych PL2766367T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE201110116373 DE102011116373A1 (de) 2011-10-14 2011-10-14 Methode zur Herstellung von 4-Amino-3-arylamino-6-arylpyrazolo[3, 4-d]pyrimidinen
DE102011116384 2011-10-20
PCT/EP2012/070403 WO2013053942A1 (de) 2011-10-14 2012-10-15 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-derivate, deren herstellung und deren verwendung als antivirale wirkstoffe

Publications (1)

Publication Number Publication Date
PL2766367T3 true PL2766367T3 (pl) 2022-08-22

Family

ID=47071252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12775659.1T PL2766367T3 (pl) 2011-10-14 2012-10-15 Pochodne 4-amino-3-fenyloamino-6-fenylopirazolo[3,4-d]pirymidyny do leczenia infekcji wirusowych, zwłaszcza infekcji pikornawirusowych

Country Status (22)

Country Link
US (1) US9790225B2 (pl)
EP (1) EP2766367B1 (pl)
JP (1) JP6071012B2 (pl)
KR (1) KR20140095467A (pl)
CN (1) CN103946224A (pl)
AU (1) AU2012322750B2 (pl)
BR (1) BR112014008815B1 (pl)
CA (1) CA2850439C (pl)
DK (1) DK2766367T3 (pl)
ES (1) ES2924828T3 (pl)
HR (1) HRP20220928T1 (pl)
HU (1) HUE059217T2 (pl)
IL (1) IL231934A (pl)
LT (1) LT2766367T (pl)
MX (1) MX2014003987A (pl)
PL (1) PL2766367T3 (pl)
PT (1) PT2766367T (pl)
RU (1) RU2014118953A (pl)
SG (2) SG11201401351PA (pl)
SI (1) SI2766367T1 (pl)
WO (1) WO2013053942A1 (pl)
ZA (1) ZA201402226B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2662822T3 (es) 2015-03-04 2018-04-09 Scandion Oncology A/S Derivados de 4-amino-3-fenilamino-6-fenilpirazol[3,4-d]pirimidina para uso como inhibidores de la BCRP en tratamientos terapéuticos
KR102205570B1 (ko) 2018-09-12 2021-01-20 김홍기 뿌리식물 수경재배용 시트

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965643A (en) 1960-12-20 Derivatives of pyrazolo
US3551428A (en) 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
DE3712735A1 (de) 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
CA2100863A1 (en) 1991-01-23 1992-07-24 David A. Bullough Adenosine kinase inhibitors
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
CZ27399A3 (cs) 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
DE102006029074A1 (de) * 2006-06-22 2007-12-27 Friedrich-Schiller-Universität Jena 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe

Also Published As

Publication number Publication date
AU2012322750A1 (en) 2014-04-24
PT2766367T (pt) 2022-08-12
CA2850439A1 (en) 2013-04-18
HUE059217T2 (hu) 2022-10-28
ZA201402226B (en) 2015-05-27
KR20140095467A (ko) 2014-08-01
BR112014008815A2 (pt) 2017-04-25
IL231934A (en) 2017-03-30
MX2014003987A (es) 2014-09-22
SG11201401351PA (en) 2014-08-28
BR112014008815B1 (pt) 2021-01-12
ES2924828T3 (es) 2022-10-11
LT2766367T (lt) 2022-08-25
US20140296259A1 (en) 2014-10-02
NZ623573A (en) 2016-08-26
RU2014118953A (ru) 2015-11-20
CN103946224A (zh) 2014-07-23
EP2766367B1 (de) 2022-05-18
US9790225B2 (en) 2017-10-17
EP2766367A1 (de) 2014-08-20
SG10201602846TA (en) 2016-05-30
IL231934A0 (en) 2014-05-28
CA2850439C (en) 2020-04-07
DK2766367T3 (da) 2022-08-01
JP2014528468A (ja) 2014-10-27
AU2012322750B2 (en) 2016-11-10
WO2013053942A1 (de) 2013-04-18
JP6071012B2 (ja) 2017-02-01
SI2766367T1 (sl) 2022-10-28
HRP20220928T1 (hr) 2022-10-28

Similar Documents

Publication Publication Date Title
HK1256490A1 (zh) 用於治療病毒感染的嘧啶衍生物
HRP20180771T1 (hr) Derivati pirolo[3,2-d]pirimidina za liječenje virusnih infekcija i drugih bolesti
HRP20181497T1 (hr) Derivati purina za liječenje virusnih infekcija
RS56870B1 (sr) Pirolopirimidinski derivati za primenu u lečenju virusnih infekcija
HUE059217T2 (hu) 4-Amino-3-fenil-amino-6-fenil-pirazolo[3,4-d]pirimidin származékok vírusfertõzések, különösen pikornavírus fertõzések kezelésére